Ticker: XBI CUSIP: 78464A870 Class: S&P BIOTECH
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 19,896,418 | $2,425,970 | — | — |
| Q3 2025 | 22,732,860 | $2,277,833 | — | — |
| Q2 2025 | 18,096,835 | $1,500,771 | — | — |
| Q1 2025 | 13,099,558 | $1,062,374 | — | — |
| Q4 2024 | 9,555,029 | $860,526 | — | — |
| Q3 2024 | 12,740,694 | $1,258,781 | — | — |
| Q2 2024 | 11,951,617 | $1,108,034 | — | — |
| Q1 2024 | 9,882,267 | $937,728 | — | — |
| Q4 2023 | 10,162,109 | $907,375 | — | — |
| Q3 2023 | 12,832,004 | $936,993 | — | — |
| Q2 2023 | 10,308,753 | $857,688 | — | — |
| Q1 2023 | 5,122,910 | $390,417 | — | — |
| Q4 2022 | 5,110,225 | $424,149 | — | — |
| Q3 2022 | 5,019,739 | $398 | — | — |
| Q2 2022 | 6,597,899 | $490 | — | — |
| Q1 2022 | 5,701,763 | $512,475 | — | — |
| Q4 2021 | 8,083,203 | $904,995 | — | — |
| Q3 2021 | 6,854,054 | $861,623 | — | — |
| Q2 2021 | 6,049,295 | $819,075 | — | — |
| Q1 2021 | 10,956,453 | $1,486,243 | — | — |
| Q4 2020 | 16,092,026 | $2,265,435 | — | — |
| Q3 2020 | 12,074,187 | $1,345,427 | — | — |
| Q2 2020 | 16,108,417 | $1,803,337 | — | — |
| Q1 2020 | 17,291,761 | $1,339,074 | — | — |
| Q4 2019 | 10,635,285 | $1,011,522 | — | — |
| Q3 2019 | 6,776,749 | $516,727 | — | — |
| Q2 2019 | 6,531,616 | $572,888 | — | — |
| Q1 2019 | 8,405,975 | $761,077 | — | — |
| Q4 2018 | 6,703,130 | $480,950 | — | — |
| Q3 2018 | 8,939,007 | $856,983 | — | — |
| Q2 2018 | 8,484,535 | $807,643 | — | — |
| Q1 2018 | 7,453,526 | $653,898 | — | — |
| Q4 2017 | 5,675,214 | $481,655 | — | — |
| Q3 2017 | 5,547,708 | $480,265 | — | — |
| Q2 2017 | 6,092,406 | $470,212 | — | — |
| Q1 2017 | 5,707,677 | $395,770 | — | — |
| Q4 2016 | 4,981,486 | $294,854 | — | — |
| Q3 2016 | 9,159,168 | $607,162 | — | — |
| Q2 2016 | 7,901,998 | $427,340 | — | — |
| Q1 2016 | 11,443,328 | $591,162 | — | — |
| Q4 2015 | 9,118,651 | $640,129 | — | — |
| Q3 2015 | 14,852,646 | $924,577 | — | — |
| Q2 2015 | 4,365,723 | $1,101,210 | — | — |
| Q1 2015 | 3,611,482 | $814,389 | — | — |
| Q4 2014 | 3,290,851 | $613,612 | — | — |
| Q3 2014 | 3,378,236 | $526,903 | — | — |
| Q2 2014 | 2,723,980 | $419,466 | — | — |
| Q1 2014 | 2,010,097 | $286,399 | — | — |
| Q4 2013 | 1,592,351 | $207,324 | — | — |
| Q3 2013 | 1,020,481 | $131,805 | — | — |
| Q2 2013 | 1,057,307 | $110,235 | — | — |
| Q4 2012 | 351,306 | $30,883 | — | — |
| Q3 2012 | 265,710 | $24,820 | — | — |
| Q2 2012 | 300,000 | $26,541 | — | — |
| Q1 2012 | 163,657 | $13,168 | — | — |